| RS2076530 |
BTNL2
|
Health Risk |
risk factor |
Sarcoidosis, susceptibility to |
| RS2076550971 |
LAMB3
|
Health Risk |
Pathogenic |
— |
| RS2076615 |
PADI2
|
Health Risk |
association |
Rheumatoid arthritis, Abnormal pulmonary interstitial morphology |
| RS2076654690 |
ARSG
|
Health Risk |
Pathogenic |
— |
| RS2076693372 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS2076695154 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2076721233 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2076738 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2076739 |
TG
|
Health Risk |
Pathogenic |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS2076743263 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2076751251 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spastic paraplegia type 78, Autosomal recessive spastic paraplegia type 78 |
| RS2076754 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 1, Autoinflammatory syndrome |
| RS2076800953 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2076841806 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2076867354 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2076888595 |
ARL13B
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2076895533 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2076901423 |
BRPF1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS2076939980 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2076941615 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2076941998 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS2076942520 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS2076949269 |
ATP13A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS2076957024 |
UNC13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, UNC13A-associated neurodevelopmental disorder |
| RS2076962370 |
ATP13A2
|
Health Risk |
Pathogenic |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS2076967147 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2076970587 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS2076974450 |
COL6A3
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2076984121 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2076985517 |
UNC13A
|
Health Risk |
Likely pathogenic |
Developmental regression, Delayed speech and language development |
| RS2076988126 |
BRPF1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2076991221 |
BRPF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2076993987 |
BRPF1
|
Health Risk |
Pathogenic |
— |
| RS2076994968 |
BRPF1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS2076997522 |
BRPF1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS2077000019 |
BRPF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2077001976 |
BRPF1
|
Health Risk |
Pathogenic |
— |
| RS2077002696 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2077005160 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2077005374 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2077007633 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2077025601 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2077029293 |
BRIP1
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2077030288 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2077030784 |
MAGT1
|
Health Risk |
Pathogenic |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2077030838 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2077033566 |
ARL13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 8, Inborn genetic diseases |
| RS2077034033 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2077034404 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2077034919 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2077035315 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2077054122 |
COL6A3
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2077054270 |
KANSL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2077055015 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077057318 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS2077062359 |
BRPF1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS2077066093 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2077066926 |
KANSL1
|
Health Risk |
Likely pathogenic |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS2077071992 |
BRPF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2077088526 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2077089395 |
KANSL1
|
Health Risk |
Likely pathogenic |
— |
| RS2077095472 |
MAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia |
| RS2077097661 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2077100185 |
BRPF1
|
Health Risk |
Likely pathogenic |
— |
| RS2077100499 |
BRPF1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2077101479 |
BRPF1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS2077109424 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spastic paraplegia type 78, Autosomal recessive spastic paraplegia type 78 |
| RS2077112267 |
OPHN1
|
Health Risk |
Likely pathogenic |
— |
| RS2077113045 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2077123571 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2077123914 |
SPATA7
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2077134911 |
SPATA7
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS2077137130 |
SPATA7
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 3, Leber congenital amaurosis 3 |
| RS2077138820 |
LPIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Majeed syndrome, Majeed syndrome |
| RS2077140472 |
CSGALNACT1
|
Health Risk |
Pathogenic |
Skeletal dysplasia, mild |
| RS2077159790 |
TTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2077166492 |
UBE3A
|
Health Risk |
Likely pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2077173386 |
SNHG14;UBE3A
|
Health Risk |
Pathogenic |
— |
| RS2077187880 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2077192500 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077193721 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS2077195468 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2077209051 |
LPIN2
|
Health Risk |
Likely pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2077221203 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, KANSL1-related disorder |
| RS2077232183 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077233012 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2077262520 |
C2orf69
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation deficiency 53, Combined oxidative phosphorylation deficiency 53 |
| RS2077271255 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS2077272442 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077273106 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2077275624 |
UBE3A
|
Health Risk |
Likely pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2077275747 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS2077276411 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077276612 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077276693 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Familial hypercholesterolemia |
| RS2077280444 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Cardiovascular phenotype |
| RS2077282376 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077282480 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2077283982 |
NSUN3
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 48, Combined oxidative phosphorylation deficiency 48 |
| RS2077284206 |
NSUN3
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 48, Combined oxidative phosphorylation deficiency 48 |